Skip to main content
  • Important Safety Information
  • Prescribing Information
  • Medication Guide
  • En Español
  • Healthcare Professionals Site
  • Important Safety Information
  • Medication Guide
Once-Daily RYBELSUS® (semaglutide) tablets 7 mg or 14 mg
  • Why RYBELSUS®?
    • RYBELSUS® Results
    • RYBELSUS® vs Other Diabetes Pills
    • How RYBELSUS® Works
    • Real RYBELSUS® Stories
  • Taking RYBELSUS®
    • How to Start RYBELSUS®
    • What to Expect With RYBELSUS®
  • Savings & Support
  • FAQs
  • About Type 2 Diabetes
    • What Is Type 2 Diabetes?
    • Type 2 Diabetes Lifestyle Tips
  • Prescribing Information
  • En Español
  • Healthcare Professionals Site

Site Map

  • Why RYBELSUS®?
    • RYBELSUS® Results
    • RYBELSUS® vs Other Diabetes Pills
    • How RYBELSUS® Works
    • Real RYBELSUS® Stories
  • Taking RYBELSUS®
    • How to Start RYBELSUS®
    • What to Expect With RYBELSUS®
  • Savings & Support
  • FAQs
  • About Type 2 Diabetes
    • What Is Type 2 Diabetes?
    • Type 2 Diabetes Lifestyle Tips
RYBELSUS® Connect and Discover RYBELSUS® Terms and Conditions of Use ›
EXPAND COLLAPSE
Scroll to ISI
Scroll to Indication
  • Terms of Use
  • Privacy Notice
  • Consumer Health Privacy Notice
  • Cookie Notice
  • Privacy Request
  • Contact Us
  • About Novo Nordisk
  • Site Map

RYBELSUS® is a registered trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.

© 2024 Novo Nordisk    All rights reserved.    US24RYB00908    December 2024

Novo Nordisk logo